Short-Acting Insulin Market is projected to reach USD 10.28 Billion by 2030, growing at a CAGR of 2%: Straits Research New York, United States, July 06, 2022 (GLOBE NEWSWIRE) -- The market for short-acting insulin is highly consolidated, with Sanofi, Novo Nordisk, and Eli Lilly serving as the three most important...